Burton Karen L sold 5,880 shares of STERIS plc at $255.62 for −$1.50M on Nov 11, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Sr. Vice Pres., CFO
Sr. Vice Pres., CFO
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$1,503,045.60Shares × reported price
Shares traded
5,880Ordinary Shares
Price per share
$255.62Reported price. Read footnotes for ranges.
% of reported position traded
31.22%This security and ownership context
Holdings after
12,956Direct
Trade date
Nov 11, 2026Sell
Filed
Nov 12, 2026, 4:32 PM ET1-day reporting delay
Accession
0001628280-26-073444Code S · Transaction 399106
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 18,836 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 11, 2026Option exercise5,880$147.05$864,654Trade 399105
Nov 11, 2026Option exercise5,880$0.00$0Trade 399107
3 transaction rows in this filing. Joint filers share the same rows.

STE price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
STE · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −5.3%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Price reflects a weighted average sale price for multiple transactions ranging from $255.22 to $256.18 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2: As of November 12, 2026, 8,499 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028; 783 on October 1, 2028 and 1,775 on June 4, 2029. F3: This option to purchase 5,880 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 5,880 ordinary shares for $147.05 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.